Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000188532 | SCV000248552 | likely benign | not specified | 2015-04-06 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000224549 | SCV000280678 | likely benign | not provided | 2015-08-26 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Labcorp Genetics |
RCV001080808 | SCV000556233 | likely benign | Progressive sclerosing poliodystrophy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000188532 | SCV000707571 | benign | not specified | 2017-04-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311277 | SCV000847019 | benign | Inborn genetic diseases | 2017-09-14 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000224549 | SCV001910327 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002492867 | SCV002798504 | likely benign | Progressive sclerosing poliodystrophy; Mitochondrial DNA depletion syndrome 1; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1; Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis; Mitochondrial DNA depletion syndrome 4b | 2021-09-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000224549 | SCV004130853 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | POLG: BS1, BS2 |
Gene |
RCV000188532 | SCV000242147 | benign | not specified | 2014-08-19 | flagged submission | clinical testing | The variant is found in POLG panel(s). |
Mayo Clinic Laboratories, |
RCV000224549 | SCV000802103 | likely benign | not provided | 2016-02-29 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000188532 | SCV001742639 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000224549 | SCV001929050 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000188532 | SCV001973521 | benign | not specified | no assertion criteria provided | clinical testing |